JP4954908B2 - Evaluation method of skin quality using the amount of soluble protein in stratum corneum as an index - Google Patents

Evaluation method of skin quality using the amount of soluble protein in stratum corneum as an index Download PDF

Info

Publication number
JP4954908B2
JP4954908B2 JP2008010701A JP2008010701A JP4954908B2 JP 4954908 B2 JP4954908 B2 JP 4954908B2 JP 2008010701 A JP2008010701 A JP 2008010701A JP 2008010701 A JP2008010701 A JP 2008010701A JP 4954908 B2 JP4954908 B2 JP 4954908B2
Authority
JP
Japan
Prior art keywords
protein
soluble protein
stratum corneum
skin
adhesive tape
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2008010701A
Other languages
Japanese (ja)
Other versions
JP2009174867A (en
Inventor
雄治 勝田
毅 針谷
宏文 青木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Priority to JP2008010701A priority Critical patent/JP4954908B2/en
Publication of JP2009174867A publication Critical patent/JP2009174867A/en
Application granted granted Critical
Publication of JP4954908B2 publication Critical patent/JP4954908B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Sampling And Sample Adjustment (AREA)

Description

本発明は、角層タンパク質の可溶性タンパク質の不溶性タンパク質に対する量比を測定することで、肌質を評価する方法に関する。   The present invention relates to a method for evaluating skin quality by measuring a quantitative ratio of soluble protein to insoluble protein of stratum corneum protein.

肌質(または皮膚の状態)を的確に把握することは、より健康な皮膚を維持するための的確なスキンケアをするうえで重要である。そのため、化粧品によるスキンケアを実施するに際し、例えば、美容技術者による問診などを通じて、化粧品の使用者の肌質が評価されてきた。また、肌質の客観的な評価を目的として、各種の計測機器を使用して、観察または測定されるパラメーターにより、皮膚の状態または機能を評価することも行われている。   Accurate grasping of skin quality (or skin condition) is important for accurate skin care for maintaining healthier skin. Therefore, when performing skin care with cosmetics, the skin quality of cosmetic users has been evaluated through, for example, an inquiry by a beauty engineer. In addition, for the purpose of objective evaluation of skin quality, the state or function of the skin is also evaluated using various types of measuring devices and the parameters observed or measured.

このようなパラメーターの代表的なものとしては、皮膚表面のレプリカを拡大して皮溝や皮丘を観察する皮膚表面形態、角層の伝導度(コンダクタンス)測定による角層水分量、経表皮水分喪失量(transepidermal water loss;TEWL)の測定による角層バリアー機能などが挙げられる。   Typical examples of such parameters are skin surface morphology by magnifying a replica of the skin surface and observing skin grooves and cuticles, stratum corneum water content by conductance measurement, and transepidermal water. Examples include a stratum corneum barrier function by measuring a transepidermal water loss (TEWL).

また、角層の保湿能の指標として天然保湿因子(natural moisturizing factor;NMF、具体的には種々の遊離アミノ酸など)を定量したり、角層中のサイトカインやカルプロテクチンといった特定のタンパク質の定量により肌質を評価する方法も応用されつつある(たとえば、特開平10−216106号公報、特開2007−33201号公報など)。しかしながら、これらはELISAなどによりタンパク質をアッセイする必要があり、手間がかかるという問題がある。   In addition, natural moisturizing factor (NMF, specifically various free amino acids, etc.) is quantified as an index of the moisturizing ability of the stratum corneum, and specific proteins such as cytokines and calprotectin in the stratum corneum are quantified. Also, methods for evaluating skin quality are being applied (for example, JP-A-10-216106, JP-A-2007-33201, etc.). However, these have the problem that it is necessary to assay the protein by ELISA or the like, which is troublesome.

角層は、表皮角化細胞が終末分化して形成された角質細胞と、それをとりまく細胞間脂質から構成される。細胞間脂質は、セラミド、コレステロール、脂肪酸などを成分としてラメラ構造を形成し、角層バリアー機能において重要な役割を演じていることが明らかになってきている。これは、角層バリアー機能が低下する種々の皮膚疾患や、肌荒れなどの皮膚トラブルを伴う場合において、細胞間脂質が形態的にまた組成的にも乱れていることにより裏付けられている。   The stratum corneum is composed of keratinocytes formed by terminal differentiation of epidermal keratinocytes and intercellular lipids surrounding them. It has become clear that intercellular lipids play an important role in the stratum corneum barrier function by forming a lamellar structure using ceramide, cholesterol, fatty acid and the like as components. This is supported by the fact that intercellular lipids are disordered both morphologically and compositionally in cases involving various skin diseases in which the stratum corneum barrier function decreases and skin troubles such as rough skin.

一方、角質細胞は、ケラチン線維を主成分とし、それを包むコーニファイドエンベロープ(CE)から構成される。CEは、表皮角化細胞が分化するにしたがって産生される複数のCE前駆体タンパクが、酵素トランスグルタミナーゼにより架橋され不溶化して形成される。さらに、その一部には、セラミドなどが共有結合し、疎水的な構造をとることで、前述した細胞間脂質のラメラ構造の土台を供給し角層バリアー機能の基礎を形成することが示唆されている。   On the other hand, keratinocytes are composed of a keratin fiber as a main component and a confined envelope (CE) enclosing it. CE is formed by cross-linking and insolubilizing a plurality of CE precursor proteins produced as epidermal keratinocytes differentiate with the enzyme transglutaminase. Furthermore, it is suggested that ceramide, etc. is covalently bonded to a part of it and forms a hydrophobic structure, thereby providing the foundation of the lamellar structure of the intercellular lipid described above and forming the basis of the stratum corneum barrier function. ing.

CEは、皮膚組織または培養皮膚細胞などを、ドデシル硫酸ナトリウムなどの界面活性剤およびメルカプトエタノールなどの還元剤を含む溶液中で煮沸し、遠心分離などの手段により可溶性成分を除去した不溶性画分を得ることにより調製できる。これを顕微鏡で形態観察することにより、その性状を評価することができる。Michel らは、角層の最外層に比較して角層の深部においては、脆弱な構造のCEが多いことを報告している(J. Invest. Dermatol 91:11−15,1988)。一方、乾癬や葉状魚鱗癬などでは最外層においても脆弱なCEが認められるとしている(Br. J. Dermatol. 122:15−21,1990)。   CE boiled skin tissue or cultured skin cells in a solution containing a surfactant such as sodium dodecyl sulfate and a reducing agent such as mercaptoethanol, and an insoluble fraction from which soluble components have been removed by means such as centrifugation. It can be prepared by obtaining. By observing the form with a microscope, the property can be evaluated. Michel et al. Report that there are more CEs with a fragile structure deeper in the stratum corneum than in the outermost layer of the stratum corneum (J. Invest. Dermatol 91: 11-15, 1988). On the other hand, it is said that fragile CE is also observed in the outermost layer in psoriasis and phylloid ichthyosis (Br. J. Dermatol. 122: 15-21, 1990).

特開2001−91514号公報はCEの染色性を利用した肌質評価方法を開示する。詳しくは、それは皮膚由来の角層試料におけるCEを、疎水性領域を選択的に染色できる色素で染色し、該CEの染色性を評価の指標とする。CE染色法はビジュアルデーターとしては優れるが、定量性がなく、またその方法もやや複雑であり、皮膚サンプルを大量のアッセイする際に難点がある。   Japanese Patent Application Laid-Open No. 2001-91514 discloses a skin quality evaluation method using the dyeability of CE. Specifically, it stains CE in a skin-derived stratum corneum sample with a dye that can selectively stain a hydrophobic region, and uses the staining property of the CE as an index for evaluation. Although the CE staining method is excellent as visual data, it is not quantitative and the method is somewhat complicated, and there is a difficulty in assaying a large amount of skin samples.

特開平10−216106号公報Japanese Patent Laid-Open No. 10-216106 特開2007−33201号公報JP 2007-33201 A 特開2001−91514号公報JP 2001-91514 A J. Invest. Dermatol 91:11−15,1988J. Invest. Dermatol 91: 11-15, 1988 Br. J. Dermatol. 122:15−21,1990Br. J. Dermatol. 122: 15-21, 1990

肌質、具体的には肌荒れ状態を定量的に、しかも簡便な方法で評価することが可能となれば、皮膚学的・化粧学的側面において極めて有益であると予測され、例えば近年における化粧品業界などで行われている適切なスキンケア法などのアドバイスを目的とするカウンセリングサービスの提供のための有力な手段ともなり得る。   If it is possible to evaluate skin quality, specifically rough skin, quantitatively and in a simple manner, it is expected to be extremely beneficial in terms of dermatology and cosmetics. For example, the cosmetic industry in recent years It can be an effective means for providing counseling services for advice such as appropriate skin care methods.

本発明者は、上記事実を鑑み、角層中の可溶性タンパク質と不溶性タンパク質の量比と肌荒れ状態との関係を調べたところ、肌荒れ状態が進行するにつれ、可溶性タンパク質の比が高まることを見出した。   In view of the above facts, the present inventor examined the relationship between the amount ratio of soluble protein and insoluble protein in the stratum corneum and the rough skin state, and found that the ratio of the soluble protein increased as the rough skin state progressed. .

上記事実の解明に基づき、本願は以下の発明を包含する。
(1)角層タンパク質の可溶性タンパク質の量比を指標とした肌質の評価方法であって、
(a)テープストリッピングにより得た角層の付着した粘着テープ試料を水性緩衝液に浸して可溶性タンパク質を当該水性緩衝剤に溶出せしめ、
(b)当該水性緩衝液から前記粘着テープ試料を分離し、当該当性緩衝液中に溶出した可溶性タンパク質を定量し、
(c)ステップ(b)で分離した前記粘着テープ試料を次に還元剤含有緩衝液に浸して不溶性タンパク質を溶出せしめ、
(d)当該還元剤含有水性緩衝液から前記粘着テープ試料を分離し、当該緩衝液に溶出した不溶性タンパク質を定量し、
(e)前記可溶性タンパク質の定量値の前記不溶性タンパク質の定量値に対する比を求める、
ことを含んでなる方法。
(2)前記テープストリッピングにより得た角層の付着した粘着テープ試料が予め凍結粉砕されたものである、(1)の方法。
(3)前記還元剤が2−メルカプトエタノールである、(1)又は(2)の方法。
Based on the elucidation of the above facts, the present application includes the following inventions.
(1) A skin quality evaluation method using an amount ratio of soluble protein of stratum corneum as an index,
(A) The adhesive tape sample with the stratum corneum obtained by tape stripping is immersed in an aqueous buffer solution to elute soluble protein in the aqueous buffer agent,
(B) separating the adhesive tape sample from the aqueous buffer and quantifying the soluble protein eluted in the buffer.
(C) The adhesive tape sample separated in step (b) is then immersed in a reducing agent-containing buffer to elute insoluble protein,
(D) separating the adhesive tape sample from the reducing agent-containing aqueous buffer, quantifying the insoluble protein eluted in the buffer,
(E) determining the ratio of the quantitative value of the soluble protein to the quantitative value of the insoluble protein;
A method comprising that.
(2) The method according to (1), wherein the adhesive tape sample having a stratum corneum obtained by tape stripping is freeze-ground.
(3) The method of (1) or (2), wherein the reducing agent is 2-mercaptoethanol.

本発明に従えば、角層中における可溶性タンパク質の量比が高いほど、肌があれた状態であると判断され、簡便、かつ定量的に、肌質を評価することが可能となる。   According to the present invention, the higher the ratio of soluble protein in the stratum corneum, the more skin is judged to be, and the skin quality can be evaluated easily and quantitatively.

本発明のおける測定対象となる角層はテープストリッピング法により皮膚などから採取する。テープストリッピングは、皮膚などに粘着テープ片を貼付、剥がすことで実施する。テープストリッピングの好ましい方法は、まず皮膚などの表層を例えばエタノールなどで浄化して皮脂、汚れ等を取り除き、適当なサイズ(例えば2×5cm)に切った粘着テープ片を皮膚表面の上に軽く載せ、テープ全体に均等な力を加えて平たく押さえ付け、その後均等な力で粘着テープを剥ぎ取ることで行われる。粘着テープは市販のセロファンテープなどであってよく、例えばセロテープ(登録商標)(ニチバン製)、Scotch Superstrength Mailing Tape (3M社製)等が使用できる。皮膚部分は身体のいずれの部分でもよく、例えば顔面の頬、額、手甲および体幹などを挙げることができる。   The stratum corneum to be measured in the present invention is collected from the skin or the like by a tape stripping method. Tape stripping is performed by attaching and peeling an adhesive tape piece on the skin or the like. The preferred method of tape stripping is to first clean the surface layer of the skin with ethanol, etc. to remove sebum, dirt, etc., and lightly place an adhesive tape piece cut to an appropriate size (eg 2 x 5 cm) on the skin surface. This is done by applying a uniform force to the entire tape and pressing it flat, and then peeling off the adhesive tape with a uniform force. The adhesive tape may be a commercially available cellophane tape or the like, and for example, cello tape (registered trademark) (manufactured by Nichiban), Scotch Superstrength Mailing Tape (manufactured by 3M) or the like can be used. The skin part may be any part of the body, and may include, for example, the facial cheek, forehead, back and trunk.

好ましくは、角層の付着した粘着テープを、例えば液体窒素(約−180℃)などに入れて凍結し、凍結プレス粉砕装置などで細かく粉砕し、タンパク質の溶出を容易にする。凍結プレス粉砕装置としては、例えばマイクロテック・ニチオンのクライオプレス(登録商標)などが使用できる。クライオプレスによる処理は、予めステンレス製内セル及び蓋を液体窒素で冷却し、その内部に5mm角ほどに切断したテープサンプルを入れ、これをクライオプレスにセットし、上部から加えられるパルス状の圧力により粉砕することで行うことができる。   Preferably, the adhesive tape with the stratum corneum is frozen in, for example, liquid nitrogen (about −180 ° C.) and finely pulverized with a freeze press pulverizer or the like to facilitate protein elution. As the freeze press crushing apparatus, for example, Microtech Nichion's Cryopress (registered trademark) can be used. The cryopress treatment is performed by pre-cooling the stainless steel inner cell and lid with liquid nitrogen, putting a tape sample cut to about 5 mm square inside, placing it in the cryopress, and applying the pulsed pressure applied from the top. Can be carried out by grinding.

角層の付着した粘着テープから可溶性タンパク質を溶出させるための水性緩衝液としては、生化学分野で一般に使用されているあらゆる緩衝液が使用でき、特に限定するものではなく、例えば水、生理食塩水、リン酸緩衝液、ホウ酸緩衝液、TRIS緩衝液、HEPES緩衝液、CHAPS緩衝液などが挙げられる。また、必要であれば、界面活性剤、例えばTween-20やTriton X-100などを緩衝液に加えてよい。ここでいう可溶性タンパク質とは、CEを構成する水溶性の前駆体タンパク質であって、架橋・不溶化していないものを意味し、具体的なタンパク質として、例えばインボルクリン、ロリクリン、スモール・プロリン・リッチ・プロテイン(SPR,コルニフィン)、シスタチンA、エラフィン、フィラグリン、ケラチン、エンボプラキン、デスモソーム構成タンパク質、アネキシンI、PAI−2などが挙げられる。可溶性タンパク質の抽出は室温や低温(例えば0℃前後)などで行うことができるが、必要に応じて数分、例えば1分〜30分、好ましくは10分程度の煮沸や超音波処理を与えて行ってよい。   As the aqueous buffer for eluting soluble protein from the adhesive tape with the stratum corneum attached, any buffer generally used in the biochemical field can be used, and is not particularly limited. For example, water, physiological saline , Phosphate buffer, borate buffer, TRIS buffer, HEPES buffer, CHAPS buffer, and the like. If necessary, a surfactant such as Tween-20 or Triton X-100 may be added to the buffer. The soluble protein herein means a water-soluble precursor protein that constitutes CE and is not cross-linked or insolubilized. Specific proteins include, for example, involucrin, loricrin, small proline rich, Examples include protein (SPR, cornifine), cystatin A, elafin, filaggrin, keratin, emboplatin, desmosome-constituting protein, annexin I, PAI-2, and the like. Extraction of soluble protein can be performed at room temperature or low temperature (for example, around 0 ° C.), but if necessary, boil or sonicate for several minutes, for example, 1 to 30 minutes, preferably about 10 minutes. You can go.

角層の付着した粘着テープから不溶性タンパク質を溶出させるための還元剤含有緩衝液は、上記水性緩衝液を基礎とし、還元剤として好ましくは2−メルカプトエタノールを、好ましくは0.1〜5質量%、より好ましくは1〜3質量%の濃度で含むものなどが使用できる。還元剤としてジチオスレイトールなど、生化学分野で汎用されているその他のものも使用できる。ここでいう不溶性タンパク質とは、例えばCEを構成する上記前駆体タンパク質がそのリジン残基とグルタミン酸残基との間にイソペプチド結合を形成することで、あるいはグルタミン残基同士がポリアミンの介在によってシュードイソペプチド結合を形成することで架橋・不溶化し、CEを構成するものをいう。不溶性タンパク質の抽出は室温などで行うことができるが、高温条件下、例えば煮沸などして行うのが好ましい。好ましくは、2〜10分間煮沸して抽出操作を行なう。   The reducing agent-containing buffer for eluting insoluble protein from the adhesive tape to which the stratum corneum is attached is based on the above aqueous buffer, and preferably 2-mercaptoethanol, preferably 0.1 to 5% by mass as the reducing agent. More preferably, it can be used at a concentration of 1 to 3% by mass. Other reducing agents such as dithiothreitol, which are widely used in the biochemical field, can also be used. The insoluble protein referred to here is, for example, that the above-mentioned precursor protein constituting CE forms an isopeptide bond between its lysine residue and glutamic acid residue, or the glutamine residues are pseudo-mediated by polyamines. This means that CE is formed by cross-linking and insolubilization by forming an isopeptide bond. Extraction of insoluble protein can be performed at room temperature or the like, but is preferably performed under high temperature conditions such as boiling. Preferably, the extraction operation is performed by boiling for 2 to 10 minutes.

タンパク質の定量方法は、生化学分野で汎用されているあらゆる方法が利用でき、特に制限されるものではなく、例えばローリー法、改良ローリー法、ブラッドフォード法、改良ブラッドフォード法、紫外線吸収法、ケルダール法などあらゆる方法が挙げられる。また、タンパク質の定量は市販のキットを使用して簡便に行うことが可能である。例えば、バイオラッド社のDCプロテインアッセイや、RC DCプロテインアッセイなどが利用できる。   Any method commonly used in the field of biochemistry can be used as the protein quantification method, and it is not particularly limited. All methods such as law are listed. Protein quantification can be easily performed using a commercially available kit. For example, BioRad's DC protein assay, RC DC protein assay, or the like can be used.

本発明において特に具体的な基準を規定するわけではないが、肌荒れ状態の肌質であると判定される基準は、角層中のタンパク質総量における可溶性タンパク質の質量比が例えば3%以上、特に5%以上、とすることができる。   In the present invention, no specific standard is specified, but the standard for determining that the skin quality is rough is that the mass ratio of soluble protein in the total amount of protein in the stratum corneum is, for example, 3% or more, particularly 5 % Or more.

以下、具体例を挙げて、本発明を更に具体的に説明する。なお、本発明はこれにより限定されるものではない。   Hereinafter, the present invention will be described more specifically with specific examples. In addition, this invention is not limited by this.

実験1:可溶性タンパク質及び不溶性タンパク質の定量
39人の被検者の頬部にテープストリッピングを施し、角層の付着した粘着テープ試料を作製した。粘着テープとしてはセロテープ(登録商標)(ニチバン)を使用した。この粘着テープ試料を15cm2にカットし、液体窒素(−180℃)にて凍結し、クライオプレス(登録商標)(マイクロテック・ニチオン)により凍結粉砕した。この凍結粉砕試料を0.1M Tris−HCl(pH8.0)、0.14M NaCl、0.1% Tween-20 300ml入りの1.5mlのチューブに分注し、30分放置して可溶性タンパク質を抽出させた。
このチューブを遠心分離(15,000g、10分)にかけ、上清液を取り出し、DCプロテインアッセイキット(バイオラッド)でタンパク質を定量した。
Experiment 1: Quantification of soluble protein and insoluble protein Tape stripping was performed on the cheeks of 39 subjects to prepare an adhesive tape sample with a stratum corneum attached. Cello tape (registered trademark) (Nichiban) was used as the adhesive tape. This adhesive tape sample was cut into 15 cm 2 , frozen with liquid nitrogen (−180 ° C.), and freeze-ground with Cryopress (registered trademark) (Microtech Nithion). This frozen and ground sample was dispensed into a 1.5 ml tube containing 300 ml of 0.1M Tris-HCl (pH 8.0), 0.14M NaCl, 0.1% Tween-20, and left for 30 minutes to dissolve soluble protein. Extracted.
The tube was centrifuged (15,000 g, 10 minutes), the supernatant was removed, and the protein was quantified with a DC protein assay kit (BioRad).

次に、上記チューブ内に沈降した粘着テープ試料に2.5%の2−メルカプトエタノール含有1×Laemmli Sample Buffer液を300ml加え、2分間煮沸して不溶性タンパク質を抽出させた。このチューブを遠心分離(15,000g、10分)にかけ、DCプロテインアッセイキット(バイオラッド)でタンパク質を定量した。
図1に各被験者の可溶性タンパク質量と不溶性タンパク質量との関係を示す。一般に、肌が荒れている状態が進行しているほど、角層が重層剥離し、テープストリッピングにより採取される角層の量は増大し、その結果測定されるタンパク質(可溶性及び不溶性タンパク質の両者)の総量も多くなると考えられる。図1のグラフ曲線が示すとおり、可溶性タンパク質と不溶性タンパク質の双方が高い値を示す試料、即ち、肌荒れ状態の進行している被験者の試料ほど、グラフ曲線の傾きが寝ているため、可溶性タンパク質の比率が高いことがわかる。
Next, 300 ml of 1 × Laemmli Sample Buffer solution containing 2.5% 2-mercaptoethanol was added to the adhesive tape sample settled in the tube and boiled for 2 minutes to extract insoluble protein. The tube was centrifuged (15,000 g, 10 minutes), and the protein was quantified with a DC protein assay kit (BioRad).
FIG. 1 shows the relationship between the amount of soluble protein and the amount of insoluble protein in each subject. In general, the more rough the skin is, the more stratum corneum is peeled off, and the amount of stratum corneum collected by tape stripping increases, and the resulting protein (both soluble and insoluble proteins). The total amount of is expected to increase. As the graph curve in FIG. 1 shows, the sample in which both the soluble protein and the insoluble protein have higher values, that is, the sample of the subject who is in a rough skin state, the slope of the graph curve is slanted. It can be seen that the ratio is high.

図2は実験1の結果を、横軸に可溶性タンパク質、縦軸に不溶性タンパク質に対する可溶性タンパク質の比率を示したグラフ図である。この図から、タンパク質量の多い肌荒れ試料ほど、可溶性タンパク質の比率が高くなることがわかる。よって、肌荒れ状態の角層タンパク質は、剥離量が多いだけでなく、質的に可溶性の高いタンパク質であることがわかる。   FIG. 2 is a graph showing the results of Experiment 1, with the horizontal axis representing soluble protein and the vertical axis representing the ratio of soluble protein to insoluble protein. From this figure, it can be seen that the rougher skin sample with a larger amount of protein has a higher ratio of soluble protein. Therefore, it can be seen that the stratum corneum protein in a rough skin state is not only a large amount of peel but also a qualitatively soluble protein.

実験2:可溶性タンパク質の比率とTEWLとの関係
可溶性タンパク質の比率と共に、各被検者の皮膚バリアー機能のパラメーターとしてのTEWLも調べ、可溶性タンパク質の比率とTEWLとの相関を調べた。その結果を図3に示す。(a)はVapometer(Delfin Technologies Ltd.,フィンランド)、(b)はTEWAmeter(Tewameter TM210;Courage+Khazaka.,ドイツ)によるTEWL測定値を示す。可溶性タンパク質の比率とTEWLとでは相関係数がVapometerでは0.3629、TEWAmeterでは0.372であり、ともに有意な相関が認められた。従って、TEWLの高いが高く、肌荒れ性状と可溶性タンパク質の比率が相関することがわかった。
Experiment 2: Relationship between soluble protein ratio and TEWL In addition to the soluble protein ratio, TEWL as a parameter of each subject's skin barrier function was also examined, and the correlation between the soluble protein ratio and TEWL was examined. The result is shown in FIG. (A) shows TEWL measured values by Vapometer (Delfin Technologies Ltd., Finland), and (b) shows TEWL measured values by TEWAmeter (Tewameter TM210; Courage + Khazaka., Germany). The correlation coefficient between the ratio of soluble protein and TEWL was 0.3629 for Vapometer and 0.372 for TEWAmeter, both of which were significantly correlated. Therefore, it was found that the TEWL is high and the ratio of the rough protein and the soluble protein correlate.

実験3:スキンケアの効果と可溶性タンパク質の比率との関係
被験者9人について、その頬部にスキンケア処置をし、スキンケア処置前後での可溶性タンパク質比率の変化を調べた。スキンケアにはDPローション(d-program製品(化粧水(ローション2)、乳液(エマルジョン2)、クリーム(クリームAD)))を使用し、1ヶ月間にわたり連用した。その結果を図4に示す。スキンケアの前後で可溶性タンパク質比率が全て被験者において顕著に低下することがわかる。また、図5は被験者全員のDPローション連用前後での可溶性タンパク質比率の平均値を示す。スキンケアにより肌荒れ状態を改善することで、可溶性タンパク質比率が低下することがこれらの結果から明らかである。
Experiment 3: Relationship between the effect of skin care and the ratio of soluble protein Nine subjects were subjected to skin care treatment on their cheeks, and the change in the soluble protein ratio before and after the skin care treatment was examined. DP lotion (d-program products (lotion (lotion 2), milky lotion (emulsion 2), cream (cream AD))) was used for skin care and continued for 1 month. The result is shown in FIG. It can be seen that all soluble protein ratios are significantly reduced in subjects before and after skin care. Moreover, FIG. 5 shows the average value of the soluble protein ratio before and after DP lotion continuous use of all the subjects. It is clear from these results that the soluble protein ratio is reduced by improving the rough skin by skin care.

可溶性タンパク質量と不溶性タンパク質量との関係。Relationship between the amount of soluble protein and the amount of insoluble protein. 実験1の結果を、横軸に可溶性タンパク質、縦軸に不溶性タンパク質に対する可溶性タンパク質の比率を示したグラフ図。The graph which showed the ratio of the soluble protein with respect to the insoluble protein for the result of Experiment 1 on the horizontal axis | shaft on the horizontal axis | shaft, and the vertical axis | shaft. 可溶性タンパク質の比率とTEWLとの関係。Relationship between soluble protein ratio and TEWL. スキンケアの効果と可溶性タンパク質の比率との関係。Relationship between skin care effect and soluble protein ratio. スキンケアの効果と可溶性タンパク質の比率との関係。Relationship between skin care effect and soluble protein ratio.

Claims (3)

角層タンパク質の可溶性タンパク質の量比を指標とした肌質の評価方法であって、
(a)テープストリッピングにより得た角層の付着した粘着テープ試料を水性緩衝液に浸して可溶性タンパク質を当該水性緩衝剤に溶出せしめ、
(b)当該水性緩衝液から前記粘着テープ試料を分離し、当該当性緩衝液中に溶出した可溶性タンパク質を定量し、
(c)ステップ(b)で分離した前記粘着テープ試料を次に還元剤含有緩衝液に浸して不溶性タンパク質を溶出せしめ、
(d)当該還元剤含有水性緩衝液から前記粘着テープ試料を分離し、当該緩衝液に溶出した不溶性タンパク質を定量し、
(e)前記可溶性タンパク質の定量値の前記不溶性タンパク質の定量値に対する比を求める、
ことを含んでなる方法。
An evaluation method of skin quality using an amount ratio of soluble protein of stratum corneum as an index,
(A) The adhesive tape sample with the stratum corneum obtained by tape stripping is immersed in an aqueous buffer solution to elute soluble protein in the aqueous buffer agent,
(B) separating the adhesive tape sample from the aqueous buffer and quantifying the soluble protein eluted in the buffer.
(C) The adhesive tape sample separated in step (b) is then immersed in a reducing agent-containing buffer to elute insoluble protein,
(D) separating the adhesive tape sample from the reducing agent-containing aqueous buffer, quantifying the insoluble protein eluted in the buffer,
(E) determining the ratio of the quantitative value of the soluble protein to the quantitative value of the insoluble protein;
A method comprising that.
前記テープストリッピングにより得た角層の付着した粘着テープ試料が予め凍結粉砕されたものである、請求項1記載の方法。   The method according to claim 1, wherein the pressure-sensitive adhesive tape sample with the stratum corneum obtained by the tape stripping is freeze-pulverized in advance. 前記還元剤が2−メルカプトエタノールである、請求項1又は2記載の方法。   The method according to claim 1 or 2, wherein the reducing agent is 2-mercaptoethanol.
JP2008010701A 2008-01-21 2008-01-21 Evaluation method of skin quality using the amount of soluble protein in stratum corneum as an index Expired - Fee Related JP4954908B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008010701A JP4954908B2 (en) 2008-01-21 2008-01-21 Evaluation method of skin quality using the amount of soluble protein in stratum corneum as an index

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008010701A JP4954908B2 (en) 2008-01-21 2008-01-21 Evaluation method of skin quality using the amount of soluble protein in stratum corneum as an index

Publications (2)

Publication Number Publication Date
JP2009174867A JP2009174867A (en) 2009-08-06
JP4954908B2 true JP4954908B2 (en) 2012-06-20

Family

ID=41030127

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008010701A Expired - Fee Related JP4954908B2 (en) 2008-01-21 2008-01-21 Evaluation method of skin quality using the amount of soluble protein in stratum corneum as an index

Country Status (1)

Country Link
JP (1) JP4954908B2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5658696B2 (en) * 2011-02-25 2015-01-28 株式会社ファンケル Evaluation method of skin stress accumulation
JP5869116B2 (en) * 2011-07-12 2016-02-24 ザ プロクター アンド ギャンブルカンパニー Method for evaluating the condition of scalp dandruff or skin health
JP5700705B2 (en) * 2012-02-27 2015-04-15 株式会社ファンケル Method of measuring the amount of drought stress on the skin
JP6587548B2 (en) * 2015-01-28 2019-10-09 花王株式会社 Evaluation method of skin quality
JP6656946B2 (en) * 2016-02-22 2020-03-04 株式会社 資生堂 How to correct the amount of stratum corneum extracted protein
JP7400157B2 (en) * 2019-07-26 2023-12-19 株式会社ファンケル How to evaluate the turnover delay of the stratum corneum

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2904565B2 (en) * 1990-09-12 1999-06-14 ポーラ化成工業株式会社 Method for analyzing stratum corneum components
JPH09243636A (en) * 1996-03-05 1997-09-19 Kanebo Ltd Analysis of substance present on skin
JP3878787B2 (en) * 1999-07-22 2007-02-07 株式会社資生堂 Evaluation of Corned Envelope

Also Published As

Publication number Publication date
JP2009174867A (en) 2009-08-06

Similar Documents

Publication Publication Date Title
JP4954908B2 (en) Evaluation method of skin quality using the amount of soluble protein in stratum corneum as an index
Marks The stratum corneum barrier: the final frontier
Kolbe et al. Corticosteroid‐induced atrophy and barrier impairment measured by non‐invasive methods in human skin
Bhushan Biophysics of human hair: structural, nanomechanical, and nanotribological studies
Harding et al. The cornified cell envelope: an important marker of stratum corneum maturation in healthy and dry skin
TWI353449B (en) Method for evaluating transparency and moisture-re
Gao et al. Acute skin barrier disruption with repeated tape stripping: an in vivo model for damage skin barrier
RU2605300C2 (en) Method for evaluating cosmetic
Schwartz et al. The role of oxidative damage in poor scalp health: ramifications to causality and associated hair growth
CN112858655A (en) Non-invasive method for measuring skin health metabolites
Heinemann et al. Induction of a hardening phenomenon by repeated application of SLS: analysis of lipid changes in the stratum corneum.
JP6419654B2 (en) Evaluation of hair growth and scalp compressive stress
JP5653783B2 (en) Evaluation method of water retention ability in skin epidermis
Bhushan Biophysics of skin and its treatments
CN107898667B (en) Method for preparing skin care composition suitable for sensitive skin based on skin lipidomics
JP2023062016A (en) Agents for improving skin barrier function worsened due to stress
KR20070094111A (en) Method for estimating the moisturizing effect of cosmetics by measuring the roughness of stratum corneum
Schueller et al. Introduction to conditioning agents for hair and skin
JP2003024282A (en) Method for evaluating skin state
CN107669521B (en) Method for preparing bionic skin care composition suitable for morning and evening based on skin lipidomics
KR20150071856A (en) Estimation method of skin barrier function by lipid staining
JP3730154B2 (en) Evaluation method of rough lips
Zhai et al. Assessment of the subclinical irritation of surfactants: a screening open assay model
Pfeiffer Comparison of adult age estimation techniques, using an ossuary sample
JP3878787B2 (en) Evaluation of Corned Envelope

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110107

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120306

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20120308

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120314

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150323

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees